United States · Industrial & Consumer Products · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for FIBROGEN INC? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
| ROE | 22.14% | - | -119.18% | -111.49% | -105.36% | -106.99% |
|---|---|---|---|---|---|---|
| ROA | -14.91% | -6.97% | -5.96% | -5.57% | -5.27% | -5.35% |
| Gross Margin | 47.47% | 45.36% | 45.26% | 44.68% | 45.03% | 43.76% |
| Net Margin | -160.63% | -44.78% | -40.37% | -43.8% | -43.64% | -44.65% |
| Total Assets | $214,525.00K | $242,617.58K | $275,591.76K | $306,125.20K | $306,125.20K | $306,125.20K |
| Net Income | -$47,579.00K | -$15,920.12K | -$15,439.79K | -$16,213.52K | -$16,126.82K | -$16,375.63K |